The estimated Net Worth of La Rosa Abel De is at least 748$ dollars as of 7 January 2022. La De owns over 4,000 units of Virios Therapeutics stock worth over 748$ and over the last 3 years La sold VIRI stock worth over 0$.
La has made over 1 trades of the Virios Therapeutics stock since 2022, according to the Form 4 filled with the SEC. Most recently La bought 4,000 units of VIRI stock worth 23,600$ on 7 January 2022.
The largest trade La's ever made was buying 4,000 units of Virios Therapeutics stock on 7 January 2022 worth over 23,600$. On average, La trades about 800 units every 0 days since 2021. As of 7 January 2022 La still owns at least 4,000 units of Virios Therapeutics stock.
You can see the complete history of La De stock trades at the bottom of the page.
La's mailing address filed with the SEC is C/O VIRIOS THERAPEUTICS, INC., 44 MILTON AVENUE, ALPHARETTA, GA, 30009.
Over the last 4 years, insiders at Virios Therapeutics have traded over 468$ worth of Virios Therapeutics stock and bought 122,044 units worth 512,255$ . The most active insiders traders include John C Thomas、Richard James Whitley、Gregory Scott Duncan. On average, Virios Therapeutics executives and independent directors trade stock every 36 days with the average trade being worth of 874$. The most recent stock trade was executed by William Pridgen on 21 August 2023, trading 15,335 units of VIRI stock currently worth 19,936$.
Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. Its lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. The company was formerly known as Virios Therapeutics, LLC and changed its name to Virios Therapeutics, Inc. in December 2020. Virios Therapeutics, Inc. was incorporated in 2012 and is headquartered in Alpharetta, Georgia.
Virios Therapeutics executives and other stock owners filed with the SEC include: